Active ingredientAbacavirCat. No. P-A001-001CAS 136470-78-5Family · Pharmaceutical analytical standards
Abacavir
An antiretroviral against HIV, a carbocyclic guanosine analogue that inhibits the virus's reverse transcriptase: developed in the 1980s by Robert Vince and Susan Daluge, it was approved in the United States in December 1998. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It is a classic example of pharmacogenetics: before treatment, DNA is checked for the HLA-B*5701 variant, linked to a hypersensitivity reaction, as confirmed in 2008 by the PREDICT-1 study.
Go to the active ingredient →Active ingredientAbacavirCat. No. P-A001-001CAS 136470-78-5
Active ingredientAbacavir SulfateCat. No. P-A001-002CAS 188062-50-2
Pharmacopoeial impurityAbacavir EP Impurity ACat. No. P-A001-003CAS 136470-79-6
Pharmacopoeial impurityAbacavir EP Impurity BCat. No. P-A001-004CAS 1443421-69-9
Pharmacopoeial impurityAbacavir EP Impurity CCat. No. P-A001-005CAS 124752-25-6
Pharmacopoeial impurityAbacavir EP Impurity DCat. No. P-A001-006CAS 1443421-67-7
Pharmacopoeial impurityAbacavir EP Impurity ECat. No. P-A001-007CAS 208762-35-0
Pharmacopoeial impurityAbacavir EP Impurity FCat. No. P-A001-008CAS 1443421-68-8
Impurityent-Abacavir EP Impurity DCat. No. P-A001-009CAS 2079853-44-2
Pharmacopoeial impurityAbacavir USP Related Compound C HydrochlorideCat. No. P-A001-010CAS 172015-79-1
MetaboliteAbacavir-5'-glucuronideCat. No. P-A001-012CAS 384329-76-4
Isotopically labelledAbacavir-d4Cat. No. P-A001-013CAS 1260619-56-4
Isotopically labelledAbacavir-d4 HydrochlorideCat. No. P-A001-014
NitrosamineN-Nitroso AbacavirCat. No. P-A001-015
Impurity(-)-CarbovirCat. No. P-A001-016CAS 120443-30-3
ImpurityAbacavir Impurity 1 HydrochlorideCat. No. P-A001-017CAS 168960-19-8
Impurity2,6-DiaminopurineCat. No. P-A001-018CAS 1904-98-9
ImpurityAbacavir Impurity 2Cat. No. P-A001-019CAS 171887-01-7
Impurity4,6-Dichloro-2,5-diformamidopyrimidineCat. No. P-A001-020CAS 116477-30-6
Impurity4,6-Dichloropyrimidine-2,5-diamineCat. No. P-A001-021CAS 55583-59-0
ImpurityAbacavir 5'-PhosphateCat. No. P-A001-022CAS 136470-77-4
ImpurityAbacavir CarboxylateCat. No. P-A001-023CAS 384380-52-3
ImpurityAbacavir Impurity 3Cat. No. P-A001-024CAS 2514723-87-4
ImpurityAbacavir Impurity 4 HydrochlorideCat. No. P-A001-025CAS 2211067-09-1
ImpurityAbacavir Impurity 5Cat. No. P-A001-026
ImpurityAbacavir Impurity 6Cat. No. P-A001-027
ImpurityAbacavir Impurity 7Cat. No. P-A001-028
ImpurityAbacavir Impurity 8Cat. No. P-A001-029
ImpurityAbacavir N-OxideCat. No. P-A001-030CAS 1443421-70-2
Pharmacopoeial impurityAbacavir Related Compound BCat. No. P-A001-031CAS 141271-12-7
ImpurityCyclopropyldiaminopurine AbacavirCat. No. P-A001-032CAS 120503-69-7
ImpurityAbacavir Impurity 9Cat. No. P-A001-033CAS 171887-02-8
ImpurityAbacavir Impurity 10Cat. No. P-A001-034CAS 171887-03-9
ImpurityAbacavir Impurity 11Cat. No. P-A001-035CAS 136470-91-2
ImpurityAbacavir Impurity 12Cat. No. P-A001-036CAS 136522-32-2
ImpurityO-Acetyl AbacavirCat. No. P-A001-037CAS 178456-36-5
Impurityrac-trans-Abacavir HydrochlorideCat. No. P-A001-038CAS 267668-71-3No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceAbacavir sulfate CRSEDQM code Y0001561Family AbacavirNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.